Applying health economics for policy decision making: do devices differ from drugs?
暂无分享,去创建一个
Corinna Sorenson | Michael Drummond | Rosanna Tarricone | M. Drummond | C. Sorenson | R. Tarricone | Markus Siebert | M. Siebert
[1] Ameet Bakhai,et al. Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial , 2004, Circulation.
[2] M. Flather,et al. One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial , 2004, Heart.
[3] M. Drummond,et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions , 2008, International Journal of Technology Assessment in Health Care.
[4] G. Sanders,et al. Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction , 2001, Annals of Internal Medicine.
[5] M. Drummond,et al. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle , 2004, BMJ : British Medical Journal.
[6] S. Priori,et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. , 2008, Heart rhythm.
[7] Claude Sicotte,et al. The added value of thorough economic evaluation of telemedicine networks , 2010, The European Journal of Health Economics.
[8] D. Shahian,et al. Transvenous Cardioverter Defibrillators: Cost Implications of a Less Invasive Approach , 1995, Pacing and clinical electrophysiology : PACE.
[9] M. Pitt,et al. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. , 2005, Health technology assessment.
[10] M. Mcgrath. Cost Effectiveness in Health and Medicine. , 1998 .
[11] T. Walley,et al. Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost–utility study , 2005, Heart.
[12] Michael Drummond,et al. Economic evaluation for devices and drugs--same or different? , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[13] J. Daubert,et al. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. , 2006, European heart journal.
[14] R. Bolman,et al. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. , 2000, The Annals of thoracic surgery.
[15] Silvia G Priori,et al. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[16] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[17] C. Longson,et al. Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance , 2007, Heart.
[18] G. Larsen,et al. Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Economic Analysis Substudy , 2002, Circulation.
[19] Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. , 2005 .
[20] A. Dhar,et al. National Institute for Health and Clinical Excellence , 2005 .
[21] James M Brophy,et al. Cost-effectiveness of drug-eluting coronary stents in Quebec, Canada , 2005, International Journal of Technology Assessment in Health Care.
[22] Antonio Colombo,et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) , 1998, The Lancet.
[23] G. Stone,et al. Cost-Effectiveness of Coronary Stenting in Acute Myocardial Infarction: Results From the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) Trial , 2001, Circulation.
[24] Grazyna Adamiak,et al. Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .
[25] R. Goeree,et al. Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario , 2009, International Journal of Technology Assessment in Health Care.
[26] Alvin I Mushlin,et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. , 2006, Journal of the American College of Cardiology.
[27] Graham Nichol,et al. Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure , 2004, Annals of Internal Medicine.
[28] L. Goldman,et al. Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction , 2005, Circulation.
[29] H. Heidbuchel,et al. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[30] A I Mushlin,et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. , 1998, Circulation.
[31] D. Cohen,et al. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience. , 2003, American heart journal.
[32] E. DeLong,et al. Acute and long-term cost implications of coronary stenting. , 1999, Journal of the American College of Cardiology.
[33] Douglas K Owens,et al. Cost-effectiveness of implantable cardioverter-defibrillators. , 2005, The New England journal of medicine.